Literature DB >> 19293582

Double diabetes: a mixture of type 1 and type 2 diabetes in youth.

Paolo Pozzilli1, Chiara Guglielmi.   

Abstract

The increase in the incidence of type 1 diabetes (T1D), especially in children <5 years of age reported over the past decade can be attributed to changes in environmental factors, either quantitative or qualitative, rather than to an effect of genetic factors operating in such a short period of time. The notable increase in the incidence of type 2 diabetes (T2D) in children and adolescents is very likely the consequence of the increase in obesity and sedentary life style occurring in developed countries. The increase in the number of children and adolescents with a mixture of the two types of diabetes has recently come to light (i.e. subjects who are obese and/or with signs of insulin resistance as well as positive for markers of autoimmunity to beta cells). Under the current classification, it is difficult to define the type of diabetes affecting these young subjects, being classified as T2D because they are obese and insulin resistant, but also as T1D because of the presence of auto-antibodies to beta cells. There is no doubt that these subjects show an overlapping diabetes phenotype typical of both T1D and T2D suggesting that the current classification of diabetes should be revised taking into account this new form of diabetes which has called double diabetes or hybrid diabetes.

Entities:  

Mesh:

Year:  2009        PMID: 19293582     DOI: 10.1159/000207484

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  14 in total

Review 1.  Connecting type 1 and type 2 diabetes through innate immunity.

Authors:  Justin I Odegaard; Ajay Chawla
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

Review 2.  Historical and current perspectives on therapeutic potential of higher basidiomycetes: an overview.

Authors:  Ruby Varghese; Yogesh Bharat Dalvi; Prasad Y Lamrood; Bharat P Shinde; C K K Nair
Journal:  3 Biotech       Date:  2019-09-17       Impact factor: 2.406

3.  German new onset diabetes in the young incident cohort study: DiMelli study design and first-year results.

Authors:  Leonore Thümer; Kerstin Adler; Ezio Bonifacio; Frank Hofmann; Manfred Keller; Christine Milz; Axel Munte; Anette-Gabriele Ziegler
Journal:  Rev Diabet Stud       Date:  2010-11-10

4.  Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients.

Authors:  Leszek Czupryniak; Marcin Wiszniewski; Dariusz Szymański; Maciej Pawłowski; Jerzy Loba; Janusz Strzelczyk
Journal:  Obes Surg       Date:  2010-02-02       Impact factor: 4.129

5.  Protein Glycosylation in Diabetes.

Authors:  Tamara Štambuk; Olga Gornik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

6.  The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study.

Authors:  Georgeanna J Klingensmith; Laura Pyle; Silva Arslanian; Kenneth C Copeland; Leona Cuttler; Francine Kaufman; Lori Laffel; Santica Marcovina; Sherida E Tollefsen; Ruth S Weinstock; Barbara Linder
Journal:  Diabetes Care       Date:  2010-06-02       Impact factor: 19.112

Review 7.  Diabetes and its comorbidities--where East meets West.

Authors:  Alice P S Kong; Gang Xu; Nicola Brown; Wing-Yee So; Ronald C W Ma; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2013-05-28       Impact factor: 43.330

8.  Double diabetes in Saudi Arabia: A new entity or an underestimated condition.

Authors:  Rim Braham; Aus Alzaid; Asirvatham Alwin Robert; Muhammad Mujammami; Rania Ahmad Ahmad; Monther Zitouni; Samia Hasan Sobki; Mohamed Abdulaziz Al Dawish
Journal:  World J Diabetes       Date:  2016-12-15

9.  Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes.

Authors:  Teresa Rodriguez-Calvo; Olov Ekwall; Natalie Amirian; Jose Zapardiel-Gonzalo; Matthias G von Herrath
Journal:  Diabetes       Date:  2014-06-19       Impact factor: 9.461

Review 10.  Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

Authors:  Ewa Otto-Buczkowska; Natalia Jainta
Journal:  Int J Endocrinol Metab       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.